3The collaborative study group for national multicenter clinical trial of urokinase thrombolytic therapy (Correspondence: Hu Dayi, Xu Zhimin. Beijing Red Cross Chao Yao Hospital, Beijing 100020).尿激酶治疗急性心肌梗塞多中心临床试验1406例总结[J].中华心血管病杂志,1997,25(3):176-179. 被引量：138
4Beta-Blocker Evaluation of Survival Trial Investigators.A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure[].The New England Journal of Medicine.2001
5Cohn JN,Tognoni G.A randomised trial of the angiotensin-receptor blocker valsartan in chronic heart failure[].The New England Journal of Medicine.2001
6Feldman RD.Adrenergic receptor polymorphisms and cardiac function(and dysfunction): a failure to communicate[].Circulation.2001
7Hunt SA,Baker DW,Chin MH,et al.ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult:executive summary.A report of the ACC/AHA task force on practice guidelines[].Journal of the American College of Cardiology.2001
8MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Trial in Congestive Heart Failure(MERIT-HF)[].The Lancet.1999
9Exner DV,Dries DL,Domanski MJ.Lesser response to angiotensinconverting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction[].The New England Journal of Medicine.2001
10Swedberg K,Bristow MR,Cohn JN,et al.Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure[].Circulation.2002
